Diagnostic and therapeutic challenges in ectopic Cushing’s syndrome without detectable tumour focus – a case report

Ectopic adrenocorticotropin (ACTH) secretion is a rare cause of Cushing’s syndrome, often posing a diagnostic challenge, particularly when the source of excessive ACTH secretion cannot be localized. The case is presented of a 70-year-old woman with Cushing’s syndrome caused by ectopic ACTH secretion from an elusive location. Despite extensive imaging (CT, MRI, PET/CT with 68Ga-DOTATATE), no tumour site could be identified. Metyrapone led to normalization of cortisol and ACTH levels and a two-year remission. After a recurrence of hypercortisolaemia, osilodrostat therapy was initiated, achieving renewed hormonal and clinical stabilization. This case highlights the importance of pharmacotherapy with steroidogenesis inhibitors as an effective alternative to surgery in patients with an unlocalized source of ectopic ACTH secretion, and the need for long-term endocrine follow-up.

• Publication year

  2026

• Venue

  Journal of Pre-Clinical and Clinical Research

• Publication date

  2026-02-16

• Fields of study

  Not labeled

• Identifiers
  DOI 10.26444/jpccr/217869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertension and Cushing’s syndrome: hunt for the red flag

  2025cited by this paper
• An aggressive Cushing's syndrome originating from a rare thymic neuroendocrine tumor, controlled successfully with fluconazole and octreotide therapy before surgery.

  2024cited by this paper
• A Case of an Ectopic ACTH-Producing Tumor With Adrenal Shrinkage During Osilodrostat Administration

  2024cited by this paper
• Clinical features and risk factors for postoperative recurrence in patients with Cushing's syndrome of different etiologies

  2024influential reference
• Ectopic ACTH syndrome in the course of ACTH-secreting pancreatic neuroendocrine tumour in a patient with a pituitary lesion - diagnostic challenges and individual approach.

  2023cited by this paper
• Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France

  2022cited by this paper
• The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism due to Ectopic ACTH Syndrome

  2022cited by this paper
• Mechanism, diagnosis, and treatment of cyclic Cushing's syndrome: A review.

  2022cited by this paper
• The Elusive Neuroendocrine Tumor: Finding the Ectopic ACTH Source 16 Years After the Diagnosis of Cushing Syndrome

  2022cited by this paper
• Epidemiology and mortality of Cushing's syndrome.

  2021influential reference
• Cushing's syndrome due to ectopic ACTH secretion.

  2015cited by this paper
• Report

  2004cited by this paper
• Cushing's syndrome.

  2001cited by this paper

• No citing papers are available for this paper.